Author:
Yoshimura Koji,Yamauchi Tamio,Maeda Hiroshi,Kawai Tsuneo
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference18 articles.
1. Horoszewicz JS, Murphy GP. An assessment of the current use of human interferons in therapy of urological cancers. J Urol 1989;142:1173–1180.
2. Williams RD. Immunotherapy of advanced renal cancer. Eur Urol 1990; 18 (suppl 2): 46–47.
3. Kobayashi Y, Yuzawa M, Sugaya Y, Kikuchi T, Morita T, Tokue A. Changes of lymphocyte subpopulation in advanced renal cell carcinoma patients with marked response to α-interferon therapy. Jpn J Urol 1994;85:1380–1387.
4. Saitoh H, Takahashi N, Suzuki T, Kogawa T, Miura H. Interferon (IFN) therapy of renal cell carcinoma patients and changes of peripheral blood lymphocyte subsets. J Jpn Soc Cancer Ther 1995;30:956–966.
5. von Rohr A, Ghosh, AK, Thatcher N, Stern PL. Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy. Br J Cancer 1993;67:163–171.